GC
AMGN icon

Garde Capital’s Amgen AMGN Stock Holding History

Garde Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$754K Buy
2,143
+13
+0.6% +$4.63K 0.05% 111
2025
Q4 		$697K Sell
2,130
-30
-1% -$9.52K 0.04% 125
2025
Q3 		$610K Sell
2,160
-161
-7% -$46.7K 0.03% 151
2025
Q2 		$648K Buy
2,321
+86
+4% +$24.4K 0.03% 142
2025
Q1 		$696K Sell
2,235
-2
-0.1% -$591 0.04% 144
2024
Q4 		$583K Hold
2,237
– – 0.04% 130
2024
Q3 		$721K Hold
2,237
– – 0.05% 116
2024
Q2 		$699K Sell
2,237
-678
-23% -$199K 0.05% 118
2024
Q1 		$829K Buy
2,915
+7
+0.2% +$2.05K 0.06% 107
2023
Q4 		$838K Sell
2,908
-2,063
-42% -$562K 0.06% 103
2023
Q3 		$1.34M Sell
4,971
-342
-6% -$85.3K 0.11% 73
2023
Q2 		$1.18M Buy
5,313
+2,301
+76% +$534K 0.1% 83
2023
Q1 		$728K Hold
3,012
– – 0.08% 98
2022
Q4 		$791K Hold
3,012
– – 0.1% 88
2022
Q3 		$679K Hold
3,012
– – 0.09% 90
2022
Q2 		$733K Buy
3,012
+77
+3% +$18.9K 0.09% 96
2022
Q1 		$710K Buy
2,935
+194
+7% +$44.6K 0.07% 105
2021
Q4 		$617K Hold
2,741
– – 0.06% 117
2021
Q3 		$583K Hold
2,741
– – 0.06% 115
2021
Q2 		$668K Sell
2,741
-206
-7% -$50.7K 0.07% 106
2021
Q1 		$733K Buy
2,947
+1
+0% +$239 0.08% 97
2020
Q4 		$677K Buy
2,946
+499
+20% +$115K 0.08% 95
2020
Q3 		$622K Hold
2,447
– – 0.09% 88
2020
Q2 		$577K Hold
2,447
– – 0.08% 81
2020
Q1 		$496K Hold
2,447
– – 0.09% 78
2019
Q4 		$590K Sell
2,447
-220
-8% -$48.5K 0.09% 80
2019
Q3 		$516K Sell
2,667
-94
-3% -$18K 0.08% 87
2019
Q2 		$509K Hold
2,761
– – 0.08% 88
2019
Q1 		$524K Hold
2,761
– – 0.09% 81
2018
Q4 		$537K Hold
2,761
– – 0.1% 105
2018
Q3 		$531K Buy
2,761
+50
+2% +$9.85K 0.09% 113
2018
Q2 		$500K Buy
2,711
+200
+8% +$35.4K 0.09% 110
2018
Q1 		$428K Sell
2,511
-25
-1% -$4.59K 0.08% 115
2017
Q4 		$441K Buy
2,536
+125
+5% +$22.1K 0.08% 113
2017
Q3 		$449K Hold
2,411
– – 0.09% 109
2017
Q2 		$415K Hold
2,411
– – 0.1% 79
2017
Q1 		$396K Buy
2,411
+127
+6% +$21.1K 0.11% 73
2016
Q4 		$334K Buy
2,284
+530
+30% +$79.8K 0.1% 79
2016
Q3 		$243K Buy
1,754
+35
+2% +$5.92K 0.08% 125
2016
Q2 		$262K Hold
1,719
– – 0.08% 87
2016
Q1 		$258K Hold
1,719
– – 0.09% 90
2015
Q4 		$279K Sell
1,719
-35
-2% -$5.5K 0.1% 80
2015
Q3 		$243K Hold
1,754
– – 0.08% 125
2015
Q2 		$269K Buy
1,754
+60
+4% +$9.61K 0.08% 122
2015
Q1 		$271K Hold
1,694
– – 0.08% 122
2014
Q4 		$270K Sell
1,694
-60
-3% -$9.35K 0.08% 117
2014
Q3 		$246K Hold
1,754
– – 0.1% 90
2014
Q2 		$208K Buy
+1,754
New +$203K 0.08% 92

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Garde Capital's AMGN Position: Q1 2026 in Review

Garde Capital increased its Amgen (AMGN) stake by 0.61% in Q1 2026, buying an estimated $4.63K and bringing the position to 2,143 shares worth $754K. The position accounts for 0.05% of the portfolio, ranked #111.

Garde Capital first reported a position in AMGN in Q2 2014 and has held it in 48 quarters since. The position peaked at $1.34M in Q3 2023. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Garde Capital held 2,143 shares of Amgen worth $754K as of Q1 2026.
  • Garde Capital bought 13 Amgen shares in Q1 2026, an estimated $4.63K.
  • Amgen made up 0.05% of Garde Capital's portfolio in Q1 2026, its #111 holding.
  • Garde Capital first reported a position in Amgen in Q2 2014 and has held it in 48 quarters since.
  • Garde Capital's Amgen position peaked at $1.34M in Q3 2023.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Garde Capital's 13F filing for Q1 2026, filed 29 Apr 2026.